14-50915945-G-T

Variant summary

Our verdict is Uncertain significance. The variant received 4 ACMG points: 4P and 0B. PM2PP3_Moderate

The NM_002863.5(PYGL):​c.1119C>A​(p.Phe373Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. F373F) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

PYGL
NM_002863.5 missense

Scores

4
7
8

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00200

Publications

1 publications found
Variant links:
Genes affected
PYGL (HGNC:9725): (glycogen phosphorylase L) This gene encodes a homodimeric protein that catalyses the cleavage of alpha-1,4-glucosidic bonds to release glucose-1-phosphate from liver glycogen stores. This protein switches from inactive phosphorylase B to active phosphorylase A by phosphorylation of serine residue 15. Activity of this enzyme is further regulated by multiple allosteric effectors and hormonal controls. Humans have three glycogen phosphorylase genes that encode distinct isozymes that are primarily expressed in liver, brain and muscle, respectively. The liver isozyme serves the glycemic demands of the body in general while the brain and muscle isozymes supply just those tissues. In glycogen storage disease type VI, also known as Hers disease, mutations in liver glycogen phosphorylase inhibit the conversion of glycogen to glucose and results in moderate hypoglycemia, mild ketosis, growth retardation and hepatomegaly. Alternative splicing results in multiple transcript variants encoding different isoforms.[provided by RefSeq, Feb 2011]
PYGL Gene-Disease associations (from GenCC):
  • glycogen storage disease VI
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp, Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 4 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.937

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PYGLNM_002863.5 linkc.1119C>A p.Phe373Leu missense_variant Exon 10 of 20 ENST00000216392.8 NP_002854.3 P06737-1
PYGLNM_001163940.2 linkc.1017C>A p.Phe339Leu missense_variant Exon 9 of 19 NP_001157412.1 P06737-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PYGLENST00000216392.8 linkc.1119C>A p.Phe373Leu missense_variant Exon 10 of 20 1 NM_002863.5 ENSP00000216392.7 P06737-1
PYGLENST00000532462.5 linkc.1119C>A p.Phe373Leu missense_variant Exon 10 of 20 1 ENSP00000431657.1 E9PK47
PYGLENST00000544180.6 linkc.1017C>A p.Phe339Leu missense_variant Exon 9 of 19 2 ENSP00000443787.1 P06737-2
PYGLENST00000528757.2 linkn.-5C>A upstream_gene_variant 3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461838
Hom.:
0
Cov.:
32
AF XY:
0.00000138
AC XY:
1
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53388
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111992
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.88
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Uncertain
0.080
CADD
Benign
15
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.61
.;.;D
Eigen
Benign
-0.47
Eigen_PC
Benign
-0.60
FATHMM_MKL
Benign
0.70
D
LIST_S2
Uncertain
0.95
D;D;D
M_CAP
Uncertain
0.13
D
MetaRNN
Pathogenic
0.94
D;D;D
MetaSVM
Uncertain
0.35
D
MutationAssessor
Benign
2.0
.;.;M
PhyloP100
0.0020
PrimateAI
Uncertain
0.74
T
PROVEAN
Benign
-1.8
N;N;N
REVEL
Pathogenic
0.68
Sift
Benign
0.088
T;T;T
Sift4G
Benign
0.18
T;T;T
Polyphen
0.72
P;.;D
Vest4
0.77
MutPred
0.88
Loss of ubiquitination at K371 (P = 0.1264);.;Loss of ubiquitination at K371 (P = 0.1264);
MVP
0.93
MPC
0.58
ClinPred
0.96
D
GERP RS
-6.1
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.8
Varity_R
0.73
gMVP
0.88
Mutation Taster
=24/76
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs151022264; hg19: chr14-51382663; API